Last Updated: May 21, 2024
molecularrd.com has 4 NS records, 9 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for molecularrd.com are ns-1270.awsdns-30.org, ns-930.awsdns-52.net, ns-1558.awsdns-02.co.uk, ns-421.awsdns-52.com. A records for molecularrd.com are 52.92.164.163, 52.92.194.155, 52.218.235.74, 52.218.253.90, 52.218.241.67, 52.218.220.66, 52.218.246.90, 52.218.221.66, 52.218.248.139. We have observed molecularrd.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a AmazonS3 web server at 52.92.180.107 in United States. The website's description is: "signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it."
Search DigitalStakeout Footprint to find another asset.
52.92.164.163
52.92.194.155
52.218.235.74
52.218.253.90
52.218.241.67
52.218.220.66
52.218.246.90
52.218.221.66
52.218.248.139
No DNS AAAA records
No DNS MX records
ns-1270.awsdns-30.org
ns-930.awsdns-52.net
ns-1558.awsdns-02.co.uk
ns-421.awsdns-52.com
No DNS TXT records
molecularrd.com has 1 subdomains in our inventory.
AmazonS3
52.92.180.107
United States
og:locale: en_us
og:type: article
og:title: signatera overview
og:description: signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it.
og:url: https://www.natera.com/oncology/signatera-advanced-cancer-detection/
og:site_name: natera
article:publisher: https://www.facebook.com/nateragenetics
article:modified_time: 2024-04-25t23:12:21+00:00
og:image: https://www.natera.com/wp-content/uploads/2022/08/icon-medicare.png
No certificate log entry found for molecularrd.com. Please check back at a later time.